The increasing interest in effective weight management has led to considerable research into groundbreaking treatments. Currently, Retatrutide, a dual -action glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor stimulator, has demonstrated promising results in medical trials, su